Chasing Profit in the Obesity Business

Yahoo Finance
Chasing Profit in the Obesity Business

View gallery

9 photos

Novo Nordisk's Kalundborg factory, 100 km west of Copenhagen, makes half the planet's insulin for diabetics, putting it on a list of global sites the United States sees as vital to its interests, according to a WikiLeaks cable in 2010.

Soaring diabetes rates, driven by increasing obesity, have fuelled profits at the Danish company for two decades. But now the company wants to tackle obesity head on by launching a treatment specifically to help patients lose weight.

View Comments (4)